Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: A survey of 250 critical care pharmacists from eight states;Las percepciones y las prácticas actuales en cuanto al reconocimiento y el tratamiento de delirio en la unidad de cuidado intensivo: una encuesta entre 250 farmacéuticos de cuidado critico en 8 estados

Annals of Pharmacotherapy

Volumn 45, Issue 10, 2011, Pages 1217-1229

  Devlin, John W ^a   Bhat, Shubha ^a   Roberts, Russel J ^b   Skrobik, Yoanna ^c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antipsychotic; Delirium; Haloperidol; Intensive care; Pharmacist practice patterns; Quetiapine

Indexed keywords

AMIODARONE; BENZODIAZEPINE; DEXMEDETOMIDINE; ERYTHROMYCIN; FENTANYL; FLUCONAZOLE; HALOPERIDOL; LORAZEPAM; METHADONE; METHYLPREDNISOLONE; MIDAZOLAM; PROCAINAMIDE; PROPOFOL; QUETIAPINE;

ARTICLE; CLINICAL PHARMACY; DELIRIUM; DRUG MEGADOSE; HEALTH CARE SURVEY; HUMAN; INTENSIVE CARE UNIT; NORMAL HUMAN; PHARMACIST; PRIORITY JOURNAL; QT INTERVAL;

ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; CRITICAL CARE; DELIRIUM; DRUG MONITORING; HALOPERIDOL; HUMANS; INTENSIVE CARE UNITS; INTERNET; MICHIGAN; NEW ENGLAND; PHARMACEUTICAL SERVICES; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL PRACTICE; PROFESSIONAL ROLE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; TENNESSEE; TIME MANAGEMENT;

EID: 80053966407     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q332     Document Type: Article

References (55)

1. American Psychiatric Association: task force on DSM-IV. DSM-IV sourcebook. 1st ed. Washington, DC: American Psychiatric Press, 1994.
2. Skrobik Y. Delirium prevention and treatment. Crit Care Clin 2009;25: 585-91.
3. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291:1753-62.
4. Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009;180:1092-7.
5. Ely EW, Gautam S, Margolin R, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001;27: 1892-900.
6. Girard TD, Jackson JC, Pandharipande PP, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010;38:1513-20.
7. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-41.
8. Borthwick M, Bourne R, Craig M, Egan A, Oxley J. United Kingdom Clinical Pharmacy Association: detection, prevention and treatment of delirium in critically ill patients. http://www.ics.ac.uk/intensive_care_professional/standards_and_guidelines/ukcpa_delirium_2006 (accessed 6 Apr 2011).
9. National Institute for Health and Clinical Excellence. Delirium guidelines. http://guidance.nice.org.uk/CG103 (accessed 6 Apr 2011).
10. Martin J, Heymann A, Bäsell K, et al. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care-short version. Ger Med Sci 2010;8:Doc02.
11. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001;27:859-64.
12. Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001;7:1370-9.
13. Devlin JW, Fong JJ, Fraser GL, Riker RR. Delirium assessment in the critically ill. Intensive Care Med 2007;33:929-40.
14. Pun BT, Gordon SM, Peterson JF, et al. Large-scale implementation of sedation and delirium monitoring in the intensive care unit: a report from two medical centers. Crit Care Med 2005;6:1199-205.
15. Van den Boogard M, Picckers P, van der Hoeven H, et al. Implementation of a delirium assessment tool in the ICU can influence haloperidol use. Crit Care 2009;13:R131. DOI 10.1186/cc7991
16. Lin A, Russell B, Devlin JW, Norton HJ, Evans S, Gesin G. Impact of implementing a validated delirium screening tool, with or without a multifaceted didactic and bedside educational program, on the ability of nurses to correctly assess and recognize delirium in a surgical-trauma intensive care unit. Crit Care Med 2010;38(suppl):A203.
17. Devlin JW, Fong JJ, Schumaker G, O'Connor H, Ruthazer R, Garpestad E. Use of a validated delirium assessment tool improves the ability of physicians to identify delirium in medical intensive care unit patients. Crit Care Med 2007;35:2721-4.
18. Devlin JW, Marquis F, Riker RR, et al. Combined didactic and scenariobased education improves the ability of intensive care unit staff to recognize delirium at the bedside. Crit Care 2008;12:R19. DOI 10.1186/cc6793
19. Ely EW, Stephens RK, Jackson JC, et al. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med 2004;32: 295-6.
20. Devlin JW, Fong JJ, Howard EP, et al. Assessment of delirium in the intensive care unit: nursing practices and perceptions. Am J Crit Care 2008;17:555-65.
21. Van Eijk MM, Kesecioglu J, Slooter AJ. Intensive care delirium monitoring and standardised treatment: a complete survey of Dutch intensive care units. Intensive Crit Care Nurs 2008;24:218-21.
22. Cheung CZ, Alibhai SM, Robinson M, et al. Recognition and labeling of delirium symptoms by intensivists: does it matter? Intensive Care Med 2008;34:437-46.
23. Shehabi Y, Botha JA, Boyle MS, et al. Sedation and delirium in the intensive care unit: an Australian and New Zealand perspective. Anaesth Intensive Care 2008;36:570-8.
24. Patel R, Gambrell M, Speroff T, et al. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med 2009;37:825-32.
25. Cadogan FL, Riekerk B, Vreeswijk R, et al. Current awareness of delirium in the intensive care unit: a postal survey in the Netherlands. Neth J Med 2009;67:296-300.
26. Mac Sweeney R, Barber V, Page V, et al. A national survey of the management of delirium in UK intensive care units. QJM 2010;103:243-51.
27. Forsgren LM, Eriksson M. Delirium-awareness, observation and interventions in intensive care units: a national survey of Swedish ICU head nurses. Intensive Crit Care Nurs 2010;26:296-303.
28. Devlin JW, Skrobik Y. Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role? Harv Rev Psychiatry 2011;9:1-9.
29. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999;156:1-20.
30. Food and Drug Administration. Information for healthcare professionals: haloperidol 2009. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ ucm085203.htm (accessed 2011 May 11).
31. Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38:419-27.
32. Girard TD, Pandharipande PP, Carson SS, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010;38:428-37.
33. Reade MC, O'Sullivan K, Bates S, Goldsmith D, Ainslie WR, Bellomo R. Dexmedetomidine vs haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care 2009;13:R75. DOI 10.1186/cc7890
34. Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004;30:444-9.
35. Lonergan E, Luxenberg J, Areosa Sastre A, Wyller TB. Benzodiazepines for delirium. Cochrane Database Syst Rev 2009;1:CD006379.
36. Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 2003;29:691-8.
37. MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic-or infarction-related events. Pharmacotherapy 2009;29:761-8.
38. Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med 2008;36:427-33.
39. Devlin JW, Nasraway SA Jr. Reversing oversedation in the intensive care unit: the role of pharmacists in energizing guideline efforts and overcoming protocol fatigue. Crit Care Med 2008;36:626-8.
40. Maclaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA. Critical care pharmacy services in United States hospitals. Ann Pharmacother 2006;40:612-8. DOI 10.1345/aph.1G590
41. Marquis F, Ouimet S, Riker R, Cossette M, Skrobik Y. Individual delirium symptoms: do they matter? Crit Care Med 2007;35:2533-7.
42. Pandharipande P, Ely EW. Sedative and analgesic medications: risk factors for delirium and sleep disturbances in the critically ill. Crit Care Clin 2006;22:313-27.
43. Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Pychosomatics 2009;50:206-17.
44. Pisani MA, Murphy TE, Araujo KL, Van Ness PH. Factors associated with persistent delirium after intensive care unit admission in an older medical patient population. J Crit Care 2010;25:540-7.
45. Devlin JW, Skrobik Y, Riker RR, et al. Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a double-blind, randomized, placebo-controlled pilot study. Crit Care Med 2010;38(suppl):A880.
46. Spronk PE, Riekerk B, Hofhuis J, Rommes JH. Occurrence of delirium is severely underestimated in the ICU during daily care. Neth J Med 2009;35:1276-80.
47. Skrobik Y. Haloperidol should be used sparingly. Crit Care Med 2002; 30:2612-4.
48. Devlin JW, Mallow-Corbett S, Riker RR. Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med 2010;38:S231-43.
49. Sharma ND, Rosman HS, Padhi ID, Tisdale JE. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998;81:238-40.
50. Product information. Haldol (haloperidol). Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc, February 2008.
51. Food and Drug Administraiton. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafety InformationforHeathcareProfessionals/ucm085203.htm (accessed 2011 May 11).
52. Ng TMH, Bell AM, Hong C, et al. Pharmacist monitoring of QTc interval-prolonging medications in critically ill patients: a pilot study. Ann Pharmacother 2008;42:475-82. DOI 10.1345/aph.1K458
53. Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de points in hospital settings. A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 2010;121:1047-60.
54. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs atypical antipsychotic medications. N Engl J Med 2005; 353:2335-41.
55. Devlin JW, Nava S, Fong JJ, Bahhady I, Hill NS. Survey of sedation practices during noninvasive positive-pressure ventilation to treat acute respiratory failure. Crit Care Med 2007;35:2298-302.